PRODUCT LITERATURE

Comparative Efficacy of Valsartan and Olmesartan in Mild-to-Moderate Hypertension: Results of 24-Hour Ambulatory Blood Pressure Monitoring

---

The aim of this prospective, randomized, open-label, blinded endpoint (PROBE) study was to compare the antihypertensive efficacy of 2 angiotensin II (AII) recep-tor antagonists with different pharmacologic profiles, valsartan and olmesartan, in patients with mild-to-moderate essential hypertension. After an initial 2-week washout period, 114 patients (64 men, 50 women; aged 35–70 years) were ran-domly assigned to receive valsartan 160 mg or olmesartan 20 mg once daily for 8 weeks.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Valdix

Specific Detail Info

Adv Ther 2005;22(1):32-43

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment